Bococizumab is a cutting-edge anti-PCSK9 antibody specifically developed to treat hypercholesterolemia. Such therapeutic agent works by the PCSK9 protein, a essential regulator of cholesterol concentrations. By https://www.targetmol.com/compound/bococizumab